In 2012, it was demonstrated that EVs containing miR-21 and miR-29a released by non-small cell lung cancer cell lines were targeting tumor-associated macrophages and, more specifically, the human toll-like receptor 8 (TLR8), triggering the downstream pathway. The gene discussed is TLR8; the disease is neoplasm.